Loading asset research
Serina Therapeutics Inc. Common Stock
SERNYSE · USD · StocksQuote as of · Exchange session not verified$2.30
-8.00%
Today
SER
Loading 1D prices…
Market cap
$56.4M
Volume
69.3K
52w high
$5.8352w low
$1.22Company profile
Serina Therapeutics Inc. Common Stock
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. It has a partnership agreement with Gannet BioChem to support development activities for SER-252. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
Huntsville, AL, United States
Employees
16
Fiscal year end
1231
CIK
1708599
Session & valuation
Open$2.41
Previous close$2.50
Day high$2.54
Day low$2.20
30-day avg. volume66.7K
Outstanding shares25.4M
Diluted EPS-$1.91
Latest annual period
P/E (trailing)-1.20
P/E (forward)-2.11
Price / book3.01
Beta0.09
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IMMPImmutep Limited American Depositary Shares | $55M | — | — | -$0.539 | +12.12% | Hold |
| HYPDHyperion DeFi Inc. Common Stock | $54.2M | $813.5K | -5570.56% | -$9.40 | -3.20% | Hold |
| XLOXilio Therapeutics Inc. Common Stock | $58.8M | $43.8M | -80.05% | -$4.19 | 0.00% | Buy |
| ELTXElicio Therapeutics Inc. Common Stock | $53.9M | $0.00 | — | -$2.58 | -2.84% | Buy |
| HRTXHeron Therapeutics Inc. Common Stock | $59.9M | $154.9M | -12.91% | -$0.12 | -1.47% | Hold |